Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MORGAN STANLEY insiders sold a net $8.9M of stock across 115 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 2.4% of the 40,842 shares held after it.
2 other insiders sold within 30 days.
1,502 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SCHAPIRO MARY L sold about $212.1K of MS on Jul 28, 2026; 2 other insiders sold within 30 days and 1,502 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jan 20, 2026.
The trade is 13.2% of the 128,870 shares held after it.
2 other insiders sold within 30 days.
1,502 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Head Technology & Operations Pizzi Michael A. sold about $3.7M of MS on Jul 17, 2026; 2 other insiders sold within 30 days and 1,502 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jan 20, 2026.
The trade is 5.8% of the 121,769 shares held after it.
2 other insiders sold within 30 days.
1,502 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Head Technology & Operations Pizzi Michael A. sold about $1.5M of MS on Jul 17, 2026; 2 other insiders sold within 30 days and 1,502 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jan 20, 2026.
The trade is 4.7% of the 136,809 shares held after it.
2 other insiders sold within 30 days.
1,502 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer YESHAYA SHARON sold about $1.4M of MS on Jul 16, 2026; 2 other insiders sold within 30 days and 1,502 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jan 20, 2026.
2 other insiders sold within 30 days.
1,502 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer YESHAYA SHARON sold about $2.0M of MS on Jul 16, 2026; 2 other insiders sold within 30 days and 1,502 funds added in the latest 13F quarter.
115 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
MORGAN STANLEY SMITH BARNEY LLC
Filed 2026-10-16
$534.4K
MARY L SCHAPIRO REV TRUST
Filed 2026-07-28
$212.1K
MORGAN STANLEY SMITH BARNEY LLC
Filed 2026-07-20
$869.0K
MICHAEL A. PIZZI REVOCABLE TRUST
Filed 2026-07-17
$5.2M
SHARON YESHAYA
Filed 2026-07-16
$3.5M
MS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
iShares U.S. Broker-Dealers & Securities Exchanges ETF
$230.3M position · as of 2026-06-30
17.3%
Invesco KBW Bank ETF
$498.0M position · as of 2026-05-31
9.4%
Rareview Dynamic Fixed Income ETF
$6.2M position · as of 2026-06-30
7.4%
Hennessy Large Cap Financial Fund
$1.7M position · as of 2026-07-31
5.7%
Hamlin High Dividend Equity Fund
$101.5M position · as of 2026-06-30
5.6%
COPLEY INVESTMENT FUND
$6.0M position · as of 2026-07-31
5.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$33.0M
$41.9M
$33.8M
+107%
+33%
2022
$39.4M
$31.4M
$20.4M
+81%
+18%
2021
$34.9M
$81.9M
$17.6M
+102%
+32%
2020
$29.6M
$55.4M
$14.7M
+38%
-2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $8.9M sold by insiders over 180 days, 1,502 funds added last quarter, 2 House member(s) bought in 12 months, disclosed weeks after the trade, $534.4K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM MS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM MS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM MS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
3.29x
LongTermDebt as filed 2026-06-30 (includes the current portion); equity 2026-06-30
Debt to equity MS
FY Dec 2025
3.06x
FY Dec 2024
2.72x
FY Dec 2023
2.63x
FY Dec 2022
2.34x
FY Dec 2021
2.16x
Jun 2026
3.29x
Mar 2026
3.18x
Dec 2025
3.06x
Sep 2025
2.95x
Jun 2025
2.96x
Mar 2025
2.78x
Dec 2024
2.72x
Sep 2024
2.81x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.04x
TTM operating cash flow over LongTermDebt as filed 2026-06-30 (includes the current portion)
Cash flow to debt MS
FY Dec 2025
-0.05x
FY Dec 2024
0.00x
FY Dec 2023
-0.13x
FY Dec 2022
-0.03x
FY Dec 2021
0.15x
Jun 2026
-0.04x
Mar 2026
-0.00x
Dec 2025
-0.05x
Sep 2025
-0.01x
Jun 2025
-0.06x
Mar 2025
-0.09x
Dec 2024
0.00x
Sep 2024
-0.10x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+18.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MS
FY Dec 2025
+15.6%
FY Dec 2024
+13.2%
FY Dec 2023
+9.1%
FY Dec 2022
+10.7%
FY Dec 2021
+14.5%
Jun 2026
+18.0%
Mar 2026
+16.4%
Dec 2025
+15.6%
Sep 2025
+15.1%
Jun 2025
+14.1%
Mar 2025
+13.9%
Dec 2024
+13.2%
Sep 2024
+11.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MS
FY Dec 2025
+1.3%
FY Dec 2024
+1.1%
FY Dec 2023
+0.8%
FY Dec 2022
+0.9%
FY Dec 2021
+1.3%
Jun 2026
+1.3%
Mar 2026
+1.3%
Dec 2025
+1.3%
Sep 2025
+1.2%
Jun 2025
+1.1%
Mar 2025
+1.1%
Dec 2024
+1.1%
Sep 2024
+0.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital MS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed MS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
14.51x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MS
FY Dec 2025
17.39x
FY Dec 2024
15.83x
FY Dec 2023
18.04x
FY Dec 2022
13.82x
FY Dec 2021
12.22x
Jun 2026
16.90x
Mar 2026
14.91x
Dec 2025
17.39x
Sep 2025
16.30x
Jun 2025
15.95x
Mar 2025
13.69x
Dec 2024
15.83x
Sep 2024
15.87x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$504.9B
market value at close 2026-10-23 on 2026-07-31 shares, plus LongTermDebt as filed 2026-06-30 (includes the current portion), minus cash 2026-06-30
Enterprise value MS
FY Dec 2025
$512.1B
FY Dec 2024
$381.5B
FY Dec 2023
$324.4B
FY Dec 2022
$249.4B
FY Dec 2021
$275.8B
Jun 2026
$552.7B
Mar 2026
$490.8B
Dec 2025
$512.1B
Sep 2025
$474.1B
Jun 2025
$437.0B
Mar 2025
$394.4B
Dec 2024
$381.5B
Sep 2024
$368.8B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield MS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.36x
P/E over trailing EPS growth of 40%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MS
FY Dec 2025
0.61x
FY Dec 2024
0.30x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.50x
Jun 2026
0.42x
Mar 2026
0.50x
Dec 2025
0.61x
Sep 2025
0.34x
Jun 2025
0.35x
Mar 2025
0.25x
Dec 2024
0.30x
Sep 2024
0.91x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MS ranks highest on institutional and government (79th percentile) and risk and compliance (69th), and lowest on insider conviction (10th), among Financial Services peers.
Profitability
63
Inputs
Return on equity+18.0% · 70 pct, sector of 205
Return on assets+1.3% · 55 pct, sector of 266
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
26
Inputs
Debt to equity3.29x · 10 pct, sector of 181
Cash flow to debt-0.04x · 43 pct, sector of 141
Insider conviction
10
Inputs
Net Form 4 buying (codes P and S), 180d-$8.9M · 19 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
79
Inputs
Funds adding, latest quarter1,502 · 99 pct, sector of 278
Congress net buyers, 365d0 · 37 pct, sector of 31
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$6.4M · 100 pct, sector of 40
Risk and compliance
69
Inputs
Short interest, % of float+1.2% · 69 pct, sector of 390
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Growth, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MS filings, in plain words
Are Morgan Stanley insiders buying or selling MS?
In the 180 days to 2026-10-27, Morgan Stanley insiders were net sellers, a net $8.9M across purchases and sales reported on Form 4, by 3 sellers.
Have members of Congress traded MS?
Yes. In the year to 2026-10-27, 2 House members disclosed buying MS and 2 House members disclosed selling it; the latest on record is a purchase by Dan Newhouse dated 2026-07-10.
Are there planned insider sales of MS?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $534.4K of stock; the latest, by MORGAN STANLEY SMITH BARNEY LLC, was filed 2026-10-16.
Read the full summary
In the 180 days to 2026-10-27, Morgan Stanley insiders were net sellers of MS, a net $8.9M across purchases and sales reported on Form 4 by 3 sellers. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 2 members of Congress disclosed buying MS and 2 members disclosed selling it; the latest on record is a purchase by Dan Newhouse dated 2026-07-10. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $534.4K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.